Safety Tolerability and Pharmacokinetics of Oral LABP-104 in Healthy Adult Male and Female Volunteers
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, ascending dose, multi-cohort study.
The primary objective of this study is to assess the safety and tolerability of single and
7-day repeat oral doses LABP-104 in healthy adult volunteers.